Gestronol hexanoate (SH582) and benign prostatic hypertrophy.
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008297:Male; D009929:Organ Size; D011278:Pregnanes / Q000008:administration & dosage / Q000627:therapeutic use*; D011374:Progesterone / Q000627:therapeutic use; D011467:Prostate / Q000187:drug effects / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D051381:Rats; D013737:Testis / Q000187:drug effects; D015032:Zinc / Q000378:metabolism
D006908:Hydroxyprogesterones; D011278:Pregnanes; D011374:Progesterone; D015032:Zinc